Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure

Rodrigues, Paulo Antônio; Naresse, Luiz Eduardo; Rodrigues, Maria Aparecida Marchesan; Kobayasi, Shoiti.
Acta cir. bras. ; 28(6): 453-457, 2013. ilus, tab
Artículo en Inglés | VETINDEX | ID: vti-8999

Documentos relacionados

  1. Theoretical modeling of the resistance to gastric emptying and duodenogastric reflux due to pyloric motility alone, presuming antral and duodenal quiescence.
  2. Development of Pancreatic Acinar Cell Metaplasia During Gastric Repair in a Rat Duodenal Contents Reflux Model.
  3. [Cholecystectomy as a risk factor for duodenogastric reflux].
  4. The Relationship between Primary Duodenogastric Reflux and Helicobacter pylori Gastritis in Children.
  5. Sleeve Gastrectomy with Pyloroplasty in Wistar Rats: Assessment of Gastric Emptying, Intestinal Transit, and Possible Duodenogastric Alkaline Reflux.
  6. [Gastroesophageal reflux disease in patients receiving chemotherapy: clinical, endoscopic, morphological and immunohistochemical features].
  7. Comparison between herbs used for the treatment of gastroesophageal reflux diseases(GERD)
  8. A flow visualization model of duodenogastric reflux after esophagectomy with gastric interposition.
  9. The Effect of Primary Duodenogastric Bile Reflux on the Presence and Density of <i>Helicobacter pylori</i> and on Gastritis in Childhood.
  10. Omeprazole and adenocarcinoma in the stomach of rats submitted to duodenogastric reflux. Is there a protective effect?